BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 14945354)

  • 1. Adrenal succinic dehydrogenase activity determined by the reduction of tetrazolium salt by adrenal homogenate.
    PERRY WF; CUMMING GR
    Endocrinology; 1952 Apr; 50(4):385-87. PubMed ID: 14945354
    [No Abstract]   [Full Text] [Related]  

  • 2. Coenzyme Q10 and succinate-tetrazolium reductase activity of proliferative lesions of liver.
    WATTENBERG LW; GRONVALL JA
    Proc Soc Exp Biol Med; 1960 Jul; 104():394-6. PubMed ID: 13843157
    [No Abstract]   [Full Text] [Related]  

  • 3. Histochemical localization of specific oxidative enzymes. V. The dissociation of succinic dehydrogenase from carriers by lipase and the specific histochemical localization of the dehydrogenase with phenazine methosulfate and tetrazolium salts.
    FARBER E; BUEDING E
    J Histochem Cytochem; 1956 Jul; 4(4):357-62. PubMed ID: 13346066
    [No Abstract]   [Full Text] [Related]  

  • 4. Colorimetric estimation of succinic dehydrogenase activity in the rabbit brain with tetrazolium salt.
    KAWAKITA Y
    Acta Psychiatr Neurol Scand; 1956; 31(4):459-65. PubMed ID: 13381526
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of coenzyme Q10 and menadione on succinic dehydrogenase activity as measured by tetrazolium salt reduction.
    WATTENBERG LW; LEONG JL
    J Histochem Cytochem; 1960 Jul; 8():296-303. PubMed ID: 13843158
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of tetranitro-blue tetrazolium for the cytochemical localization of succinic dehydrogenase. Cytochemical and cytological studies of sarcoma 37 ascites tumor cells.
    ROSA CG; TSOU KC
    J Cell Biol; 1963 Mar; 16(3):445-54. PubMed ID: 13974734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirement of cofactor for triphenyltetrazolium chloride reduction by succinic dehydrogenase.
    SUGIMURA T; ONO T
    Gan; 1956 Mar; 47(1):79-86. PubMed ID: 13318232
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of thyroxine upon succinic oxidase system of heart muscle and adrenal cortex of dog in vitro.
    KATSURA H
    Endocrinol Jpn; 1954 Sep; 1(1):109-15. PubMed ID: 14380180
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of the newest adrenal cortex hormone electrocortin-aldosterone on the histochemical reaction of succinic dehydrogenase].
    BAJUSZ E; SZIRMAI E
    Acta Histochem; 1955 Sep; 2(1-2):1-15. PubMed ID: 13282666
    [No Abstract]   [Full Text] [Related]  

  • 10. [Succinic dehydrogenase activity in the kidney of Mus musculus albinus; histochemical research with neotetrazolium].
    LUZZATTO L; REALE E
    Acta Histochem; 1956 Oct; 3(3-4):138-44. PubMed ID: 13381413
    [No Abstract]   [Full Text] [Related]  

  • 11. Glucose-6-phosphate dehydrogenase activity in the adrenal cortex of the sodium depleted rat: a histochemical study.
    COHEN RB; CRAWFORD JD
    Endocrinology; 1962 Feb; 70():288-90. PubMed ID: 13880309
    [No Abstract]   [Full Text] [Related]  

  • 12. The quantitative histological distribution of the succinic dehydrogenase system in the rat adrenal and the influence of hypophysectomy, ACTH, and cortisone.
    GLICK D; GREENBERG LJ
    Endocrinology; 1958 Dec; 63(6):778-84. PubMed ID: 13609550
    [No Abstract]   [Full Text] [Related]  

  • 13. Succinic dehydrogenase activity of normal and pathological tissues.
    BAAR HS
    Schweiz Z Pathol Bakteriol; 1957; 20(2):164-91. PubMed ID: 13432737
    [No Abstract]   [Full Text] [Related]  

  • 14. A QUANTITATIVE CYTOCHEMICAL TECHNIQUE FOR MEASUREMENT OF SUCCINIC DEHYDROGENASE ACTIVITY.
    DE P; CHATTERJEE R; BHATTACHARYA K
    Exp Cell Res; 1963 Nov; 32():394-400. PubMed ID: 14080682
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the succinate-neotetrazolium reductase system. Activation by vitamin K3.
    SLATER TF
    Biochem J; 1959 Oct; 73(2):314-20. PubMed ID: 13831622
    [No Abstract]   [Full Text] [Related]  

  • 16. Histochemical demonstration of succinic dehydrogenase in thin tissue sections by means of 2-(p-iodo-phenyl)-3-(p-nitrophenyl)-5-phenyl tetrazolium chloride under aerobic conditions.
    PEARSON B; DEFENDI V
    J Histochem Cytochem; 1954 Jul; 2(4):248-57. PubMed ID: 13174788
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanism of the reduction of triphenyltetrazolium chloride by succinoxidase.
    LING KH; SU TC; TUNG TC
    Arch Biochem Biophys; 1957 Sep; 71(1):126-9. PubMed ID: 13459434
    [No Abstract]   [Full Text] [Related]  

  • 18. Succinate tetrazolium reductase activity in the developing rat thymus.
    KAHRI AI; HANNUKSELA M; KARAHARJU EO
    Acta Endocrinol (Copenh); 1963 Apr; 42():564-70. PubMed ID: 13958300
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhancement of meotetrazolium staining for succinic dehydrogenase activity with cyanide.
    ARONSON W; PHARMAKIS T
    Stain Technol; 1962 Sep; 37():321. PubMed ID: 13862527
    [No Abstract]   [Full Text] [Related]  

  • 20. Neotetrazolium in determination of succinic dehydrogenase activity in the ovary.
    FORAKER AG; DENHAM SW
    Proc Soc Exp Biol Med; 1952 May; 80(1):132-4. PubMed ID: 14930095
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.